TY - JOUR T1 - Multimonth Dispensing of Antiretroviral Therapy Protects the Most Vulnerable From 2 Pandemics at Once JF - Global Health: Science and Practice JO - GLOB HEALTH SCI PRACT SP - 176 LP - 177 DO - 10.9745/GHSP-D-20-00160 VL - 8 IS - 2 AU - Ariana Moriah Traub AU - Temitayo Ifafore-Calfee AU - Benjamin Ryan Phelps Y1 - 2020/06/30 UR - http://www.ghspjournal.org/content/8/2/176.abstract N2 - Key MessagesMultimonth dispensing, which provides patients with several months of antiretroviral therapy, benefits HIV patients by decreasing the number of required clinic visits, improving retention, and improving viral suppression.With the increased spread of severe acute respiratory syndrome coronavirus 2, we encourage governments, ministries of health, and health care facilities to implement multimonth dispensing for patients with HIV who are stable to reduce clinic visits and safeguard both health care workers and patients from coronavirus disease 2019.Since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus has been identified in more than 183 countries.1 Its rapid spread is of major concern for those living in low- and middle-income countries and specifically people living with HIV (PLHIV). With the dearth of studies on HIV-coronavirus disease 2019 (COVID-19) coinfections, countries have no clear evidence on specific … ER -